CORRECTION article

Front. Cell Dev. Biol., 26 August 2022

Sec. Stem Cell Research

Volume 10 - 2022 | https://doi.org/10.3389/fcell.2022.819798

Corrigendum: SNORA72 activates the Notch1/c-Myc pathway to promote stemness transformation of ovarian cancer cells

  • 1. Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China

  • 2. Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang, China

  • 3. Liaoning Cancer Immune Peptide Drug Engineering Technology Research Center, China Medical University, Shenyang, China

  • 4. Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical University, Shenyang, China

Article metrics

View details

1,3k

Views

636

Downloads

In the original article, there was a mistake in Figure 1 as published. The transwell picture for CA in Figure 1C was mistaken and misused. The corrected Figure 1 appears below.

FIGURE 1

FIGURE 1

SNORA72 is overexpressed in ovarian cancer stems cells (OCSCs). (A) Morphology of OVCAR-3 (OV), OVCAR-3 spheroid (OS), CAOV-3 (CA), and CAOV-3 spheroid (CS) cells shown under a microscope (×10). (B) Expression of CD133 detected by flow cytometry in OV vs. OS and in CA vs. CS cells. (C) Migration abilities of OV, OS, CA, and CS cells by Transwell assay. (D) Differentiation morphology of OS and CS cells at 0, 12, 24, 48, and 72 h. (E) Hierarchical clustering analysis of small nucleolar RNA (snoRNA) expression from non-coding RNA-ChIP data in OV and OS cells. Red, higher expression levels; green, lower expression levels. (F) Relative SNORA72 expression to U6, as an endogenous control, analyzed by qRT-PCR in OV and OS cells. The SNORA72 expression in OV cells was set as 1. Data are shown as the mean ± SD from three independent experiments. **p < 0.01, ****p < 0.0001.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

SNORA72, ovarian cancer stem cells (OCSCs), Notch1, c-Myc, stemness

Citation

Zhang L, Ma R, Gao M, Zhao Y, Lv X, Zhu W, Han L, Su P, Fan Y, Yan Y, Zhao L, Ma H, Wei M and He M (2022) Corrigendum: SNORA72 activates the Notch1/c-Myc pathway to promote stemness transformation of ovarian cancer cells. Front. Cell Dev. Biol. 10:819798. doi: 10.3389/fcell.2022.819798

Received

22 November 2021

Accepted

29 July 2022

Published

26 August 2022

Volume

10 - 2022

Edited and reviewed by

Atsushi Asakura, University of Minnesota Twin Cities, United States

Updates

Copyright

*Correspondence: Miao He, ; Minjie Wei,

†These authors have contributed equally to this work

This article was submitted to Stem Cell Research, a section of the journal Frontiers in Cell and Developmental Biology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics